Literature DB >> 23449998

Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.

Rosane M B Teles1, Thomas G Graeber, Stephan R Krutzik, Dennis Montoya, Mirjam Schenk, Delphine J Lee, Evangelia Komisopoulou, Kindra Kelly-Scumpia, Rene Chun, Shankar S Iyer, Euzenir N Sarno, Thomas H Rea, Martin Hewison, John S Adams, Stephen J Popper, David A Relman, Steffen Stenger, Barry R Bloom, Genhong Cheng, Robert L Modlin.   

Abstract

Type I interferons (IFN-α and IFN-β) are important for protection against many viral infections, whereas type II interferon (IFN-γ) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN-β and IFN-γ gene expression programs. IFN-γ and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN-β and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN-γ-induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN-β and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23449998      PMCID: PMC3653587          DOI: 10.1126/science.1233665

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

1.  Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages.

Authors:  Shankar Subramanian Iyer; Amir Ali Ghaffari; Genhong Cheng
Journal:  J Immunol       Date:  2010-11-01       Impact factor: 5.422

2.  Type I interferon inhibits interleukin-1 production and inflammasome activation.

Authors:  Greta Guarda; Marion Braun; Francesco Staehli; Aubry Tardivel; Chantal Mattmann; Irmgard Förster; Matthias Farlik; Thomas Decker; Renaud A Du Pasquier; Pedro Romero; Jürg Tschopp
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

3.  T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism.

Authors:  Kristina Edfeldt; Philip T Liu; Rene Chun; Mario Fabri; Mirjam Schenk; Matthew Wheelwright; Caroline Keegan; Stephan R Krutzik; John S Adams; Martin Hewison; Robert L Modlin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

4.  Common patterns and disease-related signatures in tuberculosis and sarcoidosis.

Authors:  Jeroen Maertzdorf; January Weiner; Hans-Joachim Mollenkopf; Torsten Bauer; Antje Prasse; Joachim Müller-Quernheim; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

5.  Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages.

Authors:  Aleksey Novikov; Marco Cardone; Robert Thompson; Kevin Shenderov; Kevin D Kirschman; Katrin D Mayer-Barber; Timothy G Myers; Ronald L Rabin; Giorgio Trinchieri; Alan Sher; Carl G Feng
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

6.  Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages.

Authors:  Mario Fabri; Steffen Stenger; Dong-Min Shin; Jae-Min Yuk; Philip T Liu; Susan Realegeno; Hye-Mi Lee; Stephan R Krutzik; Mirjam Schenk; Peter A Sieling; Rosane Teles; Dennis Montoya; Shankar S Iyer; Heiko Bruns; David M Lewinsohn; Bruce W Hollis; Martin Hewison; John S Adams; Andreas Steinmeyer; Ulrich Zügel; Genhong Cheng; Eun-Kyeong Jo; Barry R Bloom; Robert L Modlin
Journal:  Sci Transl Med       Date:  2011-10-12       Impact factor: 17.956

7.  MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy.

Authors:  Philip T Liu; Matthew Wheelwright; Rosane Teles; Evangelia Komisopoulou; Kristina Edfeldt; Benjamin Ferguson; Manali D Mehta; Aria Vazirnia; Thomas H Rea; Euzenir N Sarno; Thomas G Graeber; Robert L Modlin
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

8.  Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.

Authors:  C L Cooper; C Mueller; T A Sinchaisri; C Pirmez; J Chan; G Kaplan; S M Young; I L Weissman; B R Bloom; T H Rea; R L Modlin
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

9.  Type I interferon production enhances susceptibility to Listeria monocytogenes infection.

Authors:  Ryan M O'Connell; Supriya K Saha; Sagar A Vaidya; Kevin W Bruhn; Gustavo A Miranda; Brian Zarnegar; Andrea K Perry; Bidong O Nguyen; Timothy F Lane; Tadatsugu Taniguchi; Jeff F Miller; Genhong Cheng
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

10.  Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis.

Authors:  J S Adams; M A Gacad
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  190 in total

1.  Transcriptional changes that characterize the immune reactions of leprosy.

Authors:  Kathryn M Dupnik; Thomas B Bair; Andressa O Maia; Francianne M Amorim; Marcos R Costa; Tatjana S L Keesen; Joanna G Valverde; Maria do Carmo A P Queiroz; Lúcio L Medeiros; Nelly L de Lucena; Mary E Wilson; Mauricio L Nobre; Warren D Johnson; Selma M B Jeronimo
Journal:  J Infect Dis       Date:  2014-11-14       Impact factor: 5.226

2.  Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.

Authors:  Larry Lam; Ramesh C Halder; Dennis J Montoya; Liudmilla Rubbi; Arturo Rinaldi; Bien Sagong; Sarah Weitzman; Rachel Rubattino; Ram Raj Singh; Matteo Pellegrini; Milan Fiala
Journal:  Am J Neurodegener Dis       Date:  2015-12-28

3.  The impact of ISGylation during Mycobacterium tuberculosis infection in mice.

Authors:  Jacqueline M Kimmey; Jessica A Campbell; Leslie A Weiss; Kristen J Monte; Deborah J Lenschow; Christina L Stallings
Journal:  Microbes Infect       Date:  2017-01-10       Impact factor: 2.700

Review 4.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

5.  Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Authors:  M Jeyanathan; N Thanthrige-Don; S Afkhami; R Lai; D Damjanovic; A Zganiacz; X Feng; X-D Yao; K L Rosenthal; M Fe Medina; J Gauldie; H C Ertl; Z Xing
Journal:  Mucosal Immunol       Date:  2015-04-15       Impact factor: 7.313

6.  IL-26 contributes to host defense against intracellular bacteria.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; David I Weiss; Kislay Parvatiyar; Euzenir N Sarno; Maria T Ochoa; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

7.  Mast cells fuel the fire of malaria immunopathology.

Authors:  Christian R Engwerda; Rajiv Kumar
Journal:  Nat Med       Date:  2013-06       Impact factor: 53.440

8.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

9.  Plasticity of antimicrobial and phagocytic programs in human macrophages.

Authors:  Dennis Montoya; Manali Mehta; Benjamin G Ferguson; Rosane M B Teles; Stephan R Krutzik; Daniel Cruz; Matteo Pellegrini; Robert L Modlin
Journal:  Immunology       Date:  2018-11-11       Impact factor: 7.397

10.  Deletion of the cyclic di-AMP phosphodiesterase gene (cnpB) in Mycobacterium tuberculosis leads to reduced virulence in a mouse model of infection.

Authors:  Jun Yang; Yinlan Bai; Yang Zhang; Vincent D Gabrielle; Lei Jin; Guangchun Bai
Journal:  Mol Microbiol       Date:  2014-05-23       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.